Skip to content

Effect of Platelet-rich Plasm (PRF) on Two-implant Mandibular Overdenture: a Split Mouth

Effect of Platelet-rich Plasm (PRF) on Two-implant Mandibular Overdenture: a Split Mouth

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04429373
Acronym
PRF
Enrollment
40
Registered
2020-06-12
Start date
2020-11-30
Completion date
2022-12-20
Last updated
2021-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Implant Failed, Edentulous Jaw

Keywords

dental implants, platelet-rich plasm, edentulous jaw

Brief summary

Implant retained overdentures are a cost-effective treatment for elderly patients suffering from complete tooth loss. Despite the high success rate of implants in the general population, older adults lacking all teeth are a challenging population for implant therapy, often presenting limited bone disponibility, narrow alveolar ridges, diminished bone density, scarce inserted gingiva and several co-morbidities.Thus, improving their possibility of success in implant therapy avoiding further surgical interventions is key. Platelet-rich fibrin (PRF) is a blood derivate that can be easily and economically obtained from patients and that has shown promise of reducing the complications and improving the success of implant therapy, nevertheless its benefits in patients receiving implant retained overdentures has not been stablished. It is possible that PRF can improve the results and diminish the complications of implant therapy in older adults. The investigation aims to demonstrate that the use of platelet-rich fibirn (PRF) is safe and beneficial for implant treatment in older adults suffering from complete tooth loss.

Detailed description

The investigators will conduct a split-mouth design randomized clinical trial assessing the effect of PRF in primary stability and bone/soft tissue healing around mandibular implants in edentulous elderly adults. Aim and purpose 1. To assess the effect of PRF on primary implant stability of mandibular implants in edentulous patients using resonance frequency analysis (RFA). 2. To evaluate the effect of PRF on clinical parameters related to soft tissue healing, post-surgical pain/inflammation and early complications of mandibular implants in edentulous patients. 3. To examine soft tissues volumetric changes pre and post- surgery using intraoral scans and bone changes using cone-beam computed tomography (CBCT) around mandibular implants in edentulous patients.

Interventions

PROCEDUREImplant installation with PRF membrane

Platelet-rich fibrin membrane over the buccal aspect of implant site after dental implant installation

PROCEDUREImplant installation without PRF membrane

Implant installation contralateral to the experimental side without PRF membrane

Sponsors

University of Chile
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

Allocation sequence will be masked from participant, outcome assessor and statistician

Intervention model description

We will conduct a split-mouth design randomized clinical trial

Eligibility

Sex/Gender
ALL
Age
60 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

* mandibular edentulous * \> 60 years old

Exclusion criteria

* physical or psychological impediment for dental surgery * dental extraction \< 6 months in the mandible * anticoagulant treatment

Design outcomes

Primary

MeasureTime frameDescription
Implant stability6 monthsprimary implant stability of mandibular implants in edentulous patients using resonance frequency analysis (RFA).

Secondary

MeasureTime frameDescription
Keratinized tissue thickness around implant neck6 monthsDistance in mm from the surface of keratinized gingiva 1 mm apical to implant neck to bone contact
Keratinized tissue width around implant neck6 monthsDistance in mm of keratinized tissue from implant neck to mucogingival junction

Countries

Chile

Contacts

Primary ContactFranco Cavalla, DDS PhD
icavalla@odontologia.uchile.cl+56932035746
Backup ContactPatricio Neira, DDS
pneira@odontologia.uchile.cl+56995193394

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026